Characteristics of diabetic macular edema on optical coherence tomography may change over time or after treatment

References

• MassinPBandelloFGarwegJGSafety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter Phase II studyDiabetes Care201033112399240520980427
   PubMed Web of Science ®Google Scholar
• MitchellPBandelloFSchmidt-ErfurthUThe RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edemaOphthalmology2011118461562521459215
   PubMed Web of Science ®Google Scholar
• ElmanMJBresslerNMQinHDiabetic Retinopathy Clinical Research Network: expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology201111860961421459214
   PubMed Web of Science ®Google Scholar
• NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 Phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
   PubMed Web of Science ®Google Scholar
• BrownDMSchmidt-ErfurthUDoDVIntravitreal aflibercept for diabetic macular edema: 100-week results from the VISTA and VIVID studiesOphthalmology2015122102044205226198808
   PubMed Web of Science ®Google Scholar
• WellsJAGlassmanARAyalaARAflibercept, bevacizumab, or ranibizumab for diabetic macular edema: two-year results from a comparative effectiveness randomized clinical trialOphthalmology201612361351135926935357
   PubMed Web of Science ®Google Scholar
• GerendasBSimaderCDeakGGMorphological parameters relevant for visual and anatomic outcomes during anti-VEGF therapy of diabetic macular edema in the RESTORE trialInvest Ophthalmol Vis Sci2014551317911791
   Web of Science ®Google Scholar
• GerendasBSPragerSGDeakGGMorphological parameters relevant for long-term outcomes during therapy of diabetic macular edema in the RESTORE Extension trialInvest Ophthalmol Vis Sci201556746864686
   Web of Science ®Google Scholar
• GregoriNZFeuerWRosenfeldPJNovel method for analyzing Snellen visual acuity measurementsRetina20103071046105020559157
   PubMed Web of Science ®Google Scholar
• CohenStatistical Power Analysis for the Behavioral Science2nd edHillsdale, NJLawrence Erlbaum Associates1988
   Google Scholar
• SheuSJLeeYYEarly response to ranibizumab is associated with 12-month outcome in diabetic macular edema after prior macular laser therapyOphthalmologica2017238313914628715811
   PubMed Web of Science ®Google Scholar
• WeckerTEhlkenCBühlerAFive-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNVBr J Ophthalmol2017101335335927215744
   PubMed Web of Science ®Google Scholar
• EganCZhuHLeeAThe United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedemaBr J Ophthalmol20171011758027965262
   PubMed Web of Science ®Google Scholar
• Romero-ArocaPBaget-BernaldizMPareja-RiosALopez-GalvezMNavarro-GilRVergesRDiabetic macular edema pathophysiology: vasogenic versus inflammatoryJ Diabetes Res20162016215627327761468
   PubMed Web of Science ®Google Scholar
• BresslerSBAyalaARBresslerNMDiabetic Retinopathy Clinical Research Network: persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairmentJAMA Ophthalmol201613427828526746868
   PubMed Web of Science ®Google Scholar
• JohnsonMWEtiology and treatment of macular edemaAm J Ophthalmol20091471112118789796
   PubMed Web of Science ®Google Scholar
• SpaideRFRetinal vascular cystoid macular edema: review and new theoryRetina201636101823184227328171
   PubMed Web of Science ®Google Scholar
• PelosiniLHullCCBoyceJFMchughDStanfordMRMarshallJOptical coherence tomography may be used to predict visual acuity in patients with macular edemaInvest Ophthalmol Vis Sci20115252741274820538987
   PubMed Web of Science ®Google Scholar
• ShinHJLeeSHChungHKimHCAssociation between photoreceptor integrity and visual outcome in diabetic macular edemaGraefes Arch Clin Exp Ophthalmol20122501617021874345
   PubMed Web of Science ®Google Scholar
• ShenYLiuKXuXCorrelation between visual function and photoreceptor integrity in diabetic macular edema: spectral-domain optical coherence tomographyCurr Eye Res201641339139925897822
   PubMed Web of Science ®Google Scholar
• SunJKRadwanSHSolimanAZNeural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edemaDiabetes20156472560257025633419
   PubMed Web of Science ®Google Scholar
• ItohYPetkovsekDKaiserPKSinghRPEhlersJPOptical coherence tomography features in diabetic macular edema and the impact on anti-VEGF responseOphthalmic Surg Lasers Imaging Retina2016471090891327759856
   PubMed Web of Science ®Google Scholar
• SophieRLuNCampochiaroPAPredictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumabOphthalmology201512271395140125870079
   PubMed Web of Science ®Google Scholar
• GerendasBSPragerSDeakGPredictive imaging biomarkers relevant for functional and anatomical outcomes during ranibizumab therapy of diabetic macular oedemaBr J Ophthalmol2018102219520328724636
   PubMed Web of Science ®Google Scholar
• IchiyamaYSawadaOMoriTThe effectiveness of vitrectomy for diffuse diabetic macular edema may depend on its preoperative optical coherence tomography patternGraefes Arch Clin Exp Ophthalmol201625481545155126780461
   PubMed Web of Science ®Google Scholar
• ZurDIglickiMBuschCOCT biomarkers as functional outcome predictors in diabetic macular edema treated with dexamethasone implantOphthalmology2018125226727528935399
   PubMed Web of Science ®Google Scholar
• SeoKHYuSYKimMKwakHWVisual and morphologic outcomes of intravitreal ranibizumab for diabetic macular edema based on optical coherence tomography patternsRetina201636358859526398695
   PubMed Web of Science ®Google Scholar